Patent · US Active

Use of flibanserin in the treatment of obesity

US8785458B2 · kind B2 · utility

12Cited by

10References

12Claims

0Family size

Assignee

Sprout Pharmaceuticals, Inc. · US

Inventors

Angelo Ceci · Mittelbiberach, DE
Marcus Schindler · Schwäbisch Hall, DE

Key dates

Filing date	Jul 16, 2012
Grant date	Jul 22, 2014
Priority date	—
Expiry date	Jul 16, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/335
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.